These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22223693)

  • 1. Sleeve lobectomy after induction chemoradiotherapy.
    Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
    Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
    Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy.
    Storelli E; Tutic M; Kestenholz P; Schneiter D; Opitz I; Hillinger S; Weder W
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):77-81. PubMed ID: 22290903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.
    Gonzalez M; Litzistorf Y; Krueger T; Popeskou SG; Matzinger O; Ris HB; Gronchi F; Lovis A; Peters S
    Ann Thorac Surg; 2013 Jul; 96(1):247-52. PubMed ID: 23684158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
    Deslauriers J; Grégoire J; Jacques LF; Piraux M; Guojin L; Lacasse Y
    Ann Thorac Surg; 2004 Apr; 77(4):1152-6; discussion 1156. PubMed ID: 15063224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
    Kim YT; Kang CH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sleeve resections in advanced nodal disease.
    Schirren J; Eberlein M; Fischer A; Bölükbas S
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1157-63. PubMed ID: 21454086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
    Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.
    Toyooka S; Soh J; Shien K; Sugimoto S; Yamane M; Oto T; Date H; Miyoshi S
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):568-72. PubMed ID: 22659891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer.
    Rea F; Marulli G; Schiavon M; Zuin A; Hamad AM; Rizzardi G; Perissinotto E; Sartori F
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):488-92; discussion 492. PubMed ID: 18579399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections.
    Schirren J; Bölükbas S; Bergmann T; Fisseler-Eckhoff A; Trainer S; Beqiri S
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):35-41. PubMed ID: 19169995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C; Stoelben E; Olschewski M; Hasse J
    Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
    Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.